351 related articles for article (PubMed ID: 20373881)
1. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
[TBL] [Abstract][Full Text] [Related]
2. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
Abshire R; Cockrum P; Crider J; Schlech B
Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic susceptibility pattern of rapidly growing mycobacteria.
Gayathri R; Therese KL; Deepa P; Mangai S; Madhavan HN
J Postgrad Med; 2010; 56(2):76-8. PubMed ID: 20622384
[TBL] [Abstract][Full Text] [Related]
5. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria].
Ruiz-Aragón J; García-Agudo L; Flores S; Rodríguez MJ; Marín P; García-Martos P
Rev Esp Quimioter; 2007 Dec; 20(4):429-32. PubMed ID: 18563216
[TBL] [Abstract][Full Text] [Related]
7. Combination drug testing of Mycobacterium chelonae.
Matoba AY; Lee BL; Robinson NM; Penland R; Osato MS
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2786-9. PubMed ID: 8344799
[TBL] [Abstract][Full Text] [Related]
8. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
[TBL] [Abstract][Full Text] [Related]
9. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
Hu FR; Luh KT
Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
[TBL] [Abstract][Full Text] [Related]
10. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.
Shih MH; Huang FC
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):223-9. PubMed ID: 20811055
[TBL] [Abstract][Full Text] [Related]
11. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
Hoel T; Casals JB; Eng J
APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
[TBL] [Abstract][Full Text] [Related]
12. Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
Moshirfar M; Meyer JJ; Espandar L
J Cataract Refract Surg; 2007 Nov; 33(11):1978-81. PubMed ID: 17964409
[TBL] [Abstract][Full Text] [Related]
13. The antimicrobial susceptibility of Mycobacterium chelonae isolated from corneal ulcer.
Hu FR; Chang SC; Luh KT; Hung PT
Curr Eye Res; 1997 Oct; 16(10):1056-60. PubMed ID: 9330859
[TBL] [Abstract][Full Text] [Related]
14. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
Shen GH; Wu BD; Hu ST; Lin CF; Wu KM; Chen JH
Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Özkarataş MH; Arslan N; Esen N; Özkütük AA
Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
[TBL] [Abstract][Full Text] [Related]
16. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil.
Höfling-Lima AL; de Freitas D; Sampaio JL; Leão SC; Contarini P
Cornea; 2005 Aug; 24(6):730-4. PubMed ID: 16015094
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
[TBL] [Abstract][Full Text] [Related]
19. Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth.
Cremades R; Santos A; Rodríguez JC; García-Pachón E; Ruiz M; Escribano I; Royo G
Chemotherapy; 2009; 55(2):114-8. PubMed ID: 19155619
[TBL] [Abstract][Full Text] [Related]
20. Nontuberculous mycobacterial keratitis in south Florida.
Ford JG; Huang AJ; Pflugfelder SC; Alfonso EC; Forster RK; Miller D
Ophthalmology; 1998 Sep; 105(9):1652-8. PubMed ID: 9754173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
